The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial Article

Industry Collaboration International Collaboration

cited authors

  • Reck, Martin; Socinski, Mark A.; Luft, Alexander; Szczesna, Aleksandra; Dediu, Mircea; Ramlau, Rodryg; Losonczy, Gyorgy; Molinier, Olivier; Schumann, Christian; Gralla, Richard J.; Bonomi, Philip; Brown, Jacqueline; Soldatenkova, Victoria; Chouaki, Nadia; Obasaju, Coleman; Peterson, Patrick; Thatcher, Nick

authors

Publication Date

  • June 1, 2016

webpage

published in

category

keywords

  • EQ-5D
  • Health-related quality of life
  • Lung Cancer Symptom Scale
  • Necitumumab
  • Tolerability

start page

  • 808

end page

  • 818

volume

  • 11

issue

  • 6